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nosocomial transmission during that period (9). However, 
the emergence of MDR TB in regions of high HIV prev-
alence is relatively recent (10), and the cases described 
here suggest that increased vigilance for TB and MDR TB 
among migrating health care workers might be required.
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To the Editor: Campylobacter species are well known 
to cause gastrointestinal infections in humans. However, 
extraintestinal illnesses caused by Campylobacter spp., 
including bacteremia, can also occur, primarily in immu-
nocompromised persons (1). Campylobacter gracilis is a 
newly recognized species (2) that is commonly found in the 
oral flora and that has been associated with periodontal dis-
eases and pleuropulmonary infections (3–6). Furthermore, 
a wide range of infectious etiologies caused by C. gracilis 
at different anatomic sites have been reported in the litera-
ture, suggesting its highly pathogenic potential (7,8). We 
describe a case of bacteremia due to C. gracilis compli-
cated by pneumonia.
An 80-year-old man with a history of hypertension, 
hypertensive nephropathy, and　chronic obstructive pul-
monary disease (COPD) was in his usual health status when 
he began having worsening productive cough, fevers, and 
malaise; he sought health care 5 days later at Long Island 
College Hospital (Brooklyn, NY, USA). A heavy smoker 
who was noncompliant with his COPD treatment, he had 
frequent episodes of COPD exacerbation necessitating 
chronic  maintenance with oral steroid therapy.
At physical examination, the patient appeared chroni-
cally ill and had mild respiratory distress. His temperature 
was 100.8°F, blood pressure 124/67 mm Hg, pulse 106 
beats/min, respiration 22 breaths/min, and oxygen satura-
tion 94% on room air. His heart sounds revealed tachycar-
dia without murmurs, and his lung sounds disclosed scat-
tered wheezing and rhonchi.
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Laboratory studies revealed a leukocyte count of 
14,400 cells/mm3 (reference range 4,500–11,500) with 
85% polymorphonuclear leukocytes, a hemoglobin level of 
11.7 g/dL (reference range 14.0–18.0), and a platelet count 
of 174,000/mm3 (reference range 150,000–450,000). His 
sodium level was 133 mmol/L (reference range 135–145), 
potassium 4.6 mmol/L (reference range 3.5–4.5), bicarbon-
ate 30 mEq/L (reference range 22–28), urea nitrogen 118 
mg/dL (reference range 9–23), and creatinine 5.2 mg/dL 
(reference range 0.7–1.3). A chest radiograph showed con-
solidation with large pleural effusion in the right lung. 
He was empirically given vancomycin, cefepime, and 
azithromycin. Severe respiratory distress developed, and 
the patient died a few days later. Respiratory cultures at 
that time showed Klebsiella pneumoniae and C. gracilis. 
Blood cultures were positive for C. gracilis.
C. gracilis, originally known as Bacteroides gracilis, 
was transferred to the genus Campylobacter in 1995 after 
analysis of the cellular fatty acids, respiratory quinones, 
and proteins of B. gracilis and a comparison of them with 
the corresponding chemotaxonomic features of Campylo-
bacter spp. (2). C. gracilis is a nonmotile, non–spore-form-
ing, anaerobic gram-negative rod that uniquely requires 
formate and fumarate in its metabolism. C. gracilis primar-
ily inhabits the gingival crevice and has been associated 
with a wide variety of periodontal diseases (3,7).
A study of 28 persons with chronic asymptomatic peri-
radicular lesions showed C. gracilis in 6 (21.4%), including 
2 (16.7%) of 12 who had acute apical periodontitis and 4 
(23.5%) of 17 who had acute periradicular abscess (4). C. 
gracilis has also been isolated from other anatomic sites 
and has caused severe infections such as peritonitis, pneu-
monia, and bacteremia (5,8).
Our patient had C. gracilis bacteremia complicated 
by acute respiratory distress secondary to pneumonia. Al-
though another gram-negative rod was isolated from the 
respiratory cultures, C. gracilis potentially played a major 
pathogenic role for this patient because of concomitant 
bacteremia that resulted in an unfavorable outcome. Pleu-
ropulmonary infections with C. gracilis are not surprising 
because of the frequency of its detection in the human oral 
flora. In a study of 23 isolates of C. gracilis and their as-
sociated clinical diagnosis, 7 were from patients with lung 
abscess or empyema, and 2 were from those with aspiration 
pneumonia (6).
Campylobacter spp. are commonly associated with 
extraintestinal complications, including bacteremia, in im-
munocompromised hosts. In a study of 183 patients with 
Campylobacter bacteremia, the main underlying condi-
tions were liver disease (39%) and cancer (38%). In that 
study, C. fetus was the most frequently identified species, 
found in 53% of the patients involved, followed by C. je-
juni, C. coli, and C. lari (1). In another case report, C. lari 
bacteremia was described in a patient with multiple my-
eloma (9). Although uncommon, C. gracilis bacteremia has 
been reported in the literature (8). 
Optimal antimicrobial drug treatment for C. gracilis 
remains to be established. Available antimicrobial suscep-
tibility patterns in the literature have shown conflicting re-
sults (5,10). In 1 study, penicillin susceptibility was 67% 
and cephalosporin susceptibility was 67%–84% in 23 iso-
lates of C. gracilis (6).
Further research is warranted to elucidate the mecha-
nisms of pathogenicity and virulence of C. gracilis. Its 
pathogenic potential should not be underestimated because 
of the spectrum of disease, severity of infection, and its 
possible high frequency of antimicrobial drug resistance. 
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